The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA molecular profiling in rare cancer patients from the MASTER KEY Project.
 
Hitomi Sumiyoshi Okuma
No Relationships to Disclose
 
Kan Yonemori
Honoraria - Eisai; Taiho Pharmaceutical
 
Takuji Seo
No Relationships to Disclose
 
Emi Noguchi
Consulting or Advisory Role - Chugai Pharma
Speakers' Bureau - Pfizer
 
Keiko Wakakuwa
No Relationships to Disclose
 
Ken Kato
Consulting or Advisory Role - BeiGene; MSD; Oncolys BioPharma; Oncolys BioPharma; Ono Pharmaceutical
Research Funding - Beigene (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst)
 
Hitoshi Ichikawa
Honoraria - Sysmex
 
Takashi Kohno
Research Funding - Daiichi Sankyo; Sysmex
 
Akihiro Hirakawa
Consulting or Advisory Role - Abbvie; Astellas Pharma; Nippon Boehringer Ingelheim; Nippon Shinyaku; Ono Pharmaceutical
Speakers' Bureau - Pfizer
 
Aya Kuchiba
Honoraria - Chugai Pharma
 
Taro Shibata
No Relationships to Disclose
 
Tamie Sukigara
No Relationships to Disclose
 
Kenichi Nakamura
Honoraria - Eisai; Merck Serono; Nihonkayaku; Taiho Pharmaceutical
 
Hiroyuki Mano
Employment - CureGene
Leadership - CureGene
Stock and Other Ownership Interests - CureGene
Consulting or Advisory Role - Chugai Pharma
Speakers' Bureau - Bayer; Chugai Pharma; Pfizer; Taiho Pharmaceutical
Research Funding - Daiichi Sankyo; Ono Pharmaceutical; PFDeNA; Sysmex
 
Toshirou Nishida
Honoraria - Bayer; Eisai; Kyowa Hakko Kirin; Novartis; Pfizer; Sysmex
 
Yasuhiro Fujiwara
Honoraria - AstraZeneca Japan; Daiichi Sankyo; SRL Diagnostics
Consulting or Advisory Role - AstraZeneca Japan; Bristol-Myers Squibb Japan